Screening protocol could identify candidates for neuromodulation therapies who could skip a formal in-person psychological assessment

Three-month depressive symptoms in adolescents lower with online SSIs compared with supportive control during COVID-19 pandemic

Sharp increase in deaths in Midwestern, Southern, Western jurisdictions; stimulant also involved in about four of 10 IMF-involved deaths

Pediatricians should inquire about child and family functioning; office visits should integrate behavioral, mental health surveillance

Elevated resting heart rate also associated with accelerated cognitive decline

Rare genetic variants occur more frequently in severe, extremely treatment-resistant schizophrenia versus typical schizophrenia

Amyloid-related imaging abnormalities-edema seen on brain MRI most common adverse event in participants receiving high-dose aducanumab

Likelihood of developing POU increased for those with history of drug abuse, preoperative muscle relaxant or benzodiazepine use

Pandemic and other major issues faced by their generation are causing 'devastating' mental health effects in young people

Prevalence estimates of type 2 diabetes 40 percent for those with sleep disorder, 21 percent for binge eating disorder